(AMRX) Amneal Pharmaceuticals - Performance 14.8% in 12m
AMRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
31.31%
#37 in Peer-Group
Rel. Strength
64.59%
#2694 in Stock-Universe
Total Return 12m
14.81%
#49 in Peer-Group
Total Return 5y
77.75%
#20 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 6.30 |
| High / Low | USD |
|---|---|
| 52 Week High | 9.25 USD |
| 52 Week Low | 6.35 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 70.49 |
| Buy/Sell Signal +-5 | -1.26 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AMRX (14.8%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: AMRX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AMRX
| Total Return (including Dividends) | AMRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 3.33% | 4.35% | 1.11% |
| 3 Months | -10.09% | -6.89% | 5.58% |
| 12 Months | 14.81% | -5.08% | 10.51% |
| 5 Years | 77.75% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | AMRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 46% | 65.8% | 69.9% |
| 3 Months | -34.5% | -72% | 69.3% |
| 12 Months | 2.1% | -62.2% | 43.2% |
| 5 Years | 39.9% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #104 | -0.97% | 2.20% |
| 3 Month | #128 | -3.44% | -14.84% |
| 12 Month | #49 | 20.96% | 3.90% |
| 5 Years | #22 | 18.08% | -15.00% |
FAQs
Does Amneal Pharmaceuticals (AMRX) outperform the market?
Yes,
over the last 12 months AMRX made 14.81%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months AMRX made -10.09%, while XLV made -6.89%.
Performance Comparison AMRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AMRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.3% | 2.2% | 1% | 4% |
| US NASDAQ 100 | QQQ | 2.5% | 1.9% | 1.8% | 6% |
| German DAX 40 | DAX | 4.5% | 4.1% | -15.4% | -15% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.6% | 4.3% | -0.8% | 3% |
| Hongkong Hang Seng | HSI | 1.8% | -1.7% | -18% | -13% |
| India NIFTY 50 | INDA | 4% | 4.7% | 2% | 16% |
| Brasil Bovespa | EWZ | -0% | 2.9% | -19.2% | 6% |
AMRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.6% | 1.9% | -1.8% | -8% |
| Consumer Discretionary | XLY | 2.8% | 5.1% | 10.9% | -3% |
| Consumer Staples | XLP | 2.6% | 3.6% | -0.5% | 8% |
| Energy | XLE | -3.6% | 0.4% | -2.6% | 12% |
| Financial | XLF | 3.9% | 5.9% | -1.8% | -9% |
| Health Care | XLV | 0.4% | -1% | 1.5% | 20% |
| Industrial | XLI | 3.3% | 3% | -4.6% | -3% |
| Materials | XLB | 3% | 1.9% | 0.2% | 15% |
| Real Estate | XLRE | 1.8% | 2.4% | 0% | 2% |
| Technology | XLK | 2% | 1.3% | 0.6% | 11% |
| Utilities | XLU | 0.9% | 2.8% | -7.4% | -7% |
| Aerospace & Defense | XAR | 3.3% | -2.4% | -15.9% | -28% |
| Biotech | XBI | 2.6% | -4.4% | 11.8% | 22% |
| Homebuilder | XHB | 3.9% | 8.4% | 16.4% | 24% |
| Retail | XRT | 6.2% | 3.5% | 9% | 14% |
AMRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -9.5% | -15.4% | -8.85% | 12% |
| Natural Gas | UNG | 3.1% | 6% | -17.3% | 29% |
| Gold | GLD | -1.3% | -2.9% | -29.2% | -33% |
| Silver | SLV | 3.1% | -8% | -18.6% | -8% |
| Copper | CPER | 4.8% | 1.6% | -13.9% | 6% |
AMRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.8% | 2.7% | 2.4% | 19% |
| iShares High Yield Corp. Bond | HYG | 1.8% | 2.8% | -2.7% | 6% |